ABT-239

CAS No. 460746-46-7

ABT-239 ( ABT239;ABT 239 )

Catalog No. M14550 CAS No. 460746-46-7

A potent and selective Histamine H3 receptor antagonist with Ki of 0.1-5.8 nM (human, rat H3).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 87 Get Quote
10MG 155 Get Quote
25MG 335 Get Quote
50MG 500 Get Quote
100MG 705 Get Quote
500MG 1485 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ABT-239
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent and selective Histamine H3 receptor antagonist with Ki of 0.1-5.8 nM (human, rat H3).
  • Description
    A potent and selective Histamine H3 receptor antagonist with Ki of 0.1-5.8 nM (human, rat H3); exhibits 1000-fold selectivity versus H1, H2 and H4; excellent pharmacokinetic and metabolic properties across species and good oral bioavailability.Pain Discontinued
  • Synonyms
    ABT239;ABT 239
  • Pathway
    GPCR/G Protein
  • Target
    Histamine Receptor
  • Recptor
    Histamine Receptor
  • Research Area
    Neurological Disease
  • Indication
    Pain

Chemical Information

  • CAS Number
    460746-46-7
  • Formula Weight
    330.42
  • Molecular Formula
    C22H22N2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 3.3 mg/mL
  • SMILES
    N#CC1=CC=C(C2=CC=C(OC(CCN3[C@H](C)CCC3)=C4)C4=C2)C=C1
  • Chemical Name
    Benzonitrile, 4-[2-[2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl]-5-benzofuranyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Cowart M, et al. J Med Chem. 2005 Jan 13;48(1):38-55.
2. Esbenshade TA, et al. J Pharmacol Exp Ther. 2005 Apr;313(1):165-75.
3. Bhowmik M, et al. Brain Res. 2014 Sep 18;1581:129-40.
molnova catalog
related products
  • JNJ 39220675

    JNJ 39220675 is potent and selective, brain penetrant H3 antagonist with Ki of 1.4 nM, pA2 of 9.42 for hH3.

  • Sodium butanoate

    Sodium Butyrate(Butanoic acid sodium salt) has been reported to cause hyperacetylation of histones due to its role as a histone deacetylase (HDAC) inhibitor (IC50 values are 0.3, 0.4, 0.3, mM for HDAC1, 2 and 7 respectively).

  • JNJ-18038683

    JNJ-18038683 is a potent, selective 5-HT7 receptor antagonist with pKi of 8.19 and 8.20 for rat and human 5-HT7 in cell-based assays; decreases 5-HT (100 nM)-stimulated adenylyl cyclase in rat and human 5-HT7/HEK293 cells with pKb of 8.01 and 7.99, respectively.